Bausch Health Companies Analyst Price Targets

Wall Street analyst price targets and consensus rating for Bausch Health Companies (BHC).

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

4Hold

1Sell

Consensus RatingHold# Analysts5Avg. Consensus PT$7Upside to Avg. PT+22.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Apr 27, 2026	RBC Capital	Douglas Miehm	PT Cut	Sector Perform	$10→$9
Feb 25, 2026	Barclays	Glen Santangelo	PT Cut	Equal-Weight	$8→$7
Jan 7, 2026	Truist Securities	Les Sulewski	PT Raise	Hold	$7→$8
Dec 9, 2025	Barclays	Glen Santangelo	Initiate	Equal-Weight	$8
May 2, 2025	RBC Capital	Douglas Miehm	PT Raise	Sector Perform	$9→$10
Apr 7, 2025	RBC Capital	Douglas Miehm	PT Cut	Sector Perform	$9→$9
Feb 6, 2025	Jefferies	David Steinberg	Downgrade	Buy→Hold	$12→$8
Jan 30, 2025	RBC Capital	Douglas Miehm	PT Cut	Sector Perform	$11→$10
Nov 1, 2024	RBC Capital	Douglas Miehm	PT Raise	Sector Perform	$10→$11
Aug 2, 2024	RBC Capital	Douglas Miehm	PT Cut	Sector Perform	$10→$9
Aug 2, 2024	Piper Sandler	David Amsellem	Downgrade	Neutral→Underweight	$9→$3
Jul 25, 2024	Truist Securities	Gregory Fraser	PT Cut	Hold	$8→$7
Jul 10, 2024	Raymond James	Michael Freeman	Initiate	Market Perform	$8
Apr 23, 2024	RBC Capital	Douglas Miehm	PT Cut	Sector Perform	$12→$11
Apr 12, 2024	RBC Capital	Douglas Miehm	Maintained	Sector Perform	$12
Apr 5, 2024	RBC Capital	Douglas Miehm	PT Raise	Sector Perform	$9→$12
Feb 23, 2024	RBC Capital	Douglas Miehm	PT Raise	Sector Perform	$8→$9

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
RBC Capital Maintains Sector Perform on Bausch Health Companies, Lowers Price Target to $9

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and lowers the price target from $10 to $9.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Bausch Health Companies, Lowers Price Target to $7

Barclays analyst Glen Santangelo maintains Bausch Health Companies (NYSE:BHC) with a Equal-Weight and lowers the price target from $8 to $7.

Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Bausch Health Companies, Raises Price Target to $8

Truist Securities analyst Les Sulewski maintains Bausch Health Companies (NYSE:BHC) with a Hold and raises the price target from $7 to $8.

Benzinga Newsdesk

PRO
Barclays Initiates Coverage On Bausch Health Companies with Equal-Weight Rating, Announces Price Target of $8

Barclays analyst Glen Santangelo initiates coverage on Bausch Health Companies (NYSE:BHC) with a Equal-Weight rating and announces Price Target of $8.

Benzinga Newsdesk

PRO
RBC Capital Maintains Sector Perform on Bausch Health Companies, Raises Price Target to $10

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and raises the price target from $8.5 to $10.

Benzinga Newsdesk

PRO
Jefferies Downgrades Bausch Health Companies to Hold, Lowers Price Target to $8

Jefferies analyst David Steinberg downgrades Bausch Health Companies (NYSE:BHC) from Buy to Hold and lowers the price target from $12 to $8.

Benzinga Newsdesk

Bausch Health Companies Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Bausch Health Companies Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
RBC Capital Maintains Sector Perform on Bausch Health Companies, Lowers Price Target to $9

PRO
Barclays Maintains Equal-Weight on Bausch Health Companies, Lowers Price Target to $7

PRO
Truist Securities Maintains Hold on Bausch Health Companies, Raises Price Target to $8

PRO
Barclays Initiates Coverage On Bausch Health Companies with Equal-Weight Rating, Announces Price Target of $8

PRO
RBC Capital Maintains Sector Perform on Bausch Health Companies, Raises Price Target to $10

PRO
Jefferies Downgrades Bausch Health Companies to Hold, Lowers Price Target to $8

People Also Watch

People Also Watch

Bausch Health Companies Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Bausch Health Companies Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRORBC Capital Maintains Sector Perform on Bausch Health Companies, Lowers Price Target to $9

PROBarclays Maintains Equal-Weight on Bausch Health Companies, Lowers Price Target to $7

PROTruist Securities Maintains Hold on Bausch Health Companies, Raises Price Target to $8

PROBarclays Initiates Coverage On Bausch Health Companies with Equal-Weight Rating, Announces Price Target of $8

PRORBC Capital Maintains Sector Perform on Bausch Health Companies, Raises Price Target to $10

PROJefferies Downgrades Bausch Health Companies to Hold, Lowers Price Target to $8

People Also Watch

People Also Watch

PRO
RBC Capital Maintains Sector Perform on Bausch Health Companies, Lowers Price Target to $9

PRO
Barclays Maintains Equal-Weight on Bausch Health Companies, Lowers Price Target to $7

PRO
Truist Securities Maintains Hold on Bausch Health Companies, Raises Price Target to $8

PRO
Barclays Initiates Coverage On Bausch Health Companies with Equal-Weight Rating, Announces Price Target of $8

PRO
RBC Capital Maintains Sector Perform on Bausch Health Companies, Raises Price Target to $10

PRO
Jefferies Downgrades Bausch Health Companies to Hold, Lowers Price Target to $8